Indaptus Therapeutics, Inc.
INDP
$2.45
$0.4220.91%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -18.86M | -20.85M | -16.87M | -16.96M | -15.75M |
| Total Depreciation and Amortization | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.91M | 2.51M | 2.03M | 1.96M | 1.77M |
| Change in Net Operating Assets | -836.50K | 3.51M | -190.70K | 29.70K | 541.90K |
| Cash from Operations | -16.79M | -14.82M | -15.03M | -14.97M | -13.43M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 5.71M | 5.71M | 5.71M | 5.71M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.92M | 6.40M | 8.53M | 9.19M | 8.66M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 6.00M | 6.00M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -238.30K | -569.60K | -773.50K | -1.08M | -1.07M |
| Cash from Financing | 14.39M | 17.54M | 13.47M | 13.83M | 7.58M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.39M | 2.72M | -1.56M | -1.14M | -5.85M |